DYN — Dyne Therapeutics Share News
0.000.00%
Last trade - 00:00U.S. STOCKS ON THE MOVE- Gap, Aquestive Therapeutics, Lumentum
U.S. STOCKS ON THE MOVE-Bruker Corp, Centuri Holdings, Shoe Carnival
US FDA program favorable for rare disease drug developers, says Jefferies
Brief: Dyne Therapeutics Announces FDA Breakthrough Therapy Designation For Dyne-251 In Duchenne Muscular Dystrophy
U.S. RESEARCH ROUNDUP-Cadence Design Systems, Coinbase Global, Kinsale Capital Group
Dyne Therapeutics Q2 net loss widens
U.S. STOCKS ON THE MOVE-Energy stocks, Apple, Vertex
U.S. STOCKS ON THE MOVE-Snap, Solventum, GlobalFoundries
U.S. STOCKS ON THE MOVE-NIP Group, Hyatt, BioXcel Therapeutics
U.S. STOCKS ON THE MOVE-Circle, gold miners, silver miners
Dyne Therapeutics slides on $200 mln equity raise
Brief: Dyne Therapeutics Announces Pricing Of $200.0 Million Public Offering Of Common Stock
Dyne Therapeutics slips after $200 mln stock offering launch
Brief: Dyne Therapeutics Announces Proposed Public Offering Of Common Stock
Brief: Dyne Therapeutics Secures Up to $275 Million in Debt Financing from Hercules Capital
U.S. STOCKS ON THE MOVE-Natgas companies, Eli Lilly, Kraft Heinz
U.S. STOCKS ON THE MOVE-Red Cat, Nvidia Corp, Redwire
Dyne Therapeutics falls on revised timelines for genetic disorder therapy
Brief: Dyne Therapeutics To Host Investor Conference Call And Webcast